View Larger Image Wells Fargo says AbbVie is undervalued, sees biopharma stock rallying 36% AbbVie shares are down 9.7% in the past month. Read More By David Hilbern|2022-05-02T05:14:58-05:00May 2, 2022|Bankruptcy|Comments Off on Wells Fargo says AbbVie is undervalued, sees biopharma stock rallying 36% Share This Story, Choose Your Platform! FacebookTwitterLinkedInEmail About the Author: David Hilbern Related Posts Walt Disney’s Pixar targets ‘Lightyear’ execs among 75 job cuts June 3, 2023 ‘Not just a fad’: Firm launches fund designed to capitalize on A.I. boom June 3, 2023 Judge in Disney, DeSantis case recuses himself because relative owns company’s stock June 1, 2023